Published in Diabetes Care on April 17, 2012
Adherence to therapies in patients with type 2 diabetes. Diabetes Ther (2013) 2.23
Evaluation of the Dual-Chamber Pen Design for the Injection of Exenatide Once Weekly for the Treatment of Type 2 Diabetes. J Diabetes Sci Technol (2015) 1.43
Impact of medication adherence and persistence on clinical and economic outcomes in patients with type 2 diabetes treated with liraglutide: a retrospective cohort study. Adv Ther (2015) 1.24
The relationship between diabetic retinopathy and cognitive impairment. Diabetes Care (2013) 1.01
Rationale, design and baseline characteristics of a 4-year (208-week) phase III trial of empagliflozin, an SGLT2 inhibitor, versus glimepiride as add-on to metformin in patients with type 2 diabetes mellitus with insufficient glycemic control. Cardiovasc Diabetol (2013) 1.00
A nine country study of the burden of non-severe nocturnal hypoglycaemic events on diabetes management and daily function. Diabetes Obes Metab (2013) 0.95
Into the abyss: diabetes process of care indicators and outcomes of defaulters from a Canadian tertiary care multidisciplinary diabetes clinic. BMC Health Serv Res (2013) 0.89
Early discontinuation and restart of insulin in the treatment of type 2 diabetes mellitus. Diabetes Ther (2014) 0.85
Appointment and medication non-adherence is associated with increased mortality in insulin-treated type 2 diabetes. Evid Based Med (2012) 0.84
Association between remission of macroalbuminuria and preservation of renal function in patients with type 2 diabetes with overt proteinuria. Diabetes Care (2013) 0.84
Real-world evidence studies into treatment adherence, thresholds for intervention and disparities in treatment in people with type 2 diabetes in the UK. BMJ Open (2016) 0.84
Improving the adherence of type 2 diabetes mellitus patients with pharmacy care: a systematic review of randomized controlled trials. BMC Endocr Disord (2014) 0.83
Practical Guidance on the Use of Premix Insulin Analogs in Initiating, Intensifying, or Switching Insulin Regimens in Type 2 Diabetes. Diabetes Ther (2015) 0.82
Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence (2016) 0.81
Impact of glycemic control on healthcare resource utilization and costs of type 2 diabetes: current and future pharmacologic approaches to improving outcomes. Am Health Drug Benefits (2013) 0.81
Systematic review of adherence rates by medication class in type 2 diabetes: a study protocol. BMJ Open (2016) 0.79
Adherence to GLP-1 receptor agonist therapy administered by once-daily or once-weekly injection in patients with type 2 diabetes in Germany. Diabetes Metab Syndr Obes (2016) 0.78
Development and Usability of REACH: A Tailored Theory-Based Text Messaging Intervention for Disadvantaged Adults With Type 2 Diabetes. JMIR Hum Factors (2016) 0.77
Cost-Effectiveness of Saxagliptin versus Acarbose as Second-Line Therapy in Type 2 Diabetes in China. PLoS One (2016) 0.76
The Usability of Diabetes MAP: A Web-delivered Intervention for Improving Medication Adherence. JMIR Hum Factors (2016) 0.76
Medication adherence and persistence in type 2 diabetes mellitus: perspectives of patients, physicians and pharmacists on the Spanish health care system. Patient Prefer Adherence (2017) 0.75
Cost-Effectiveness of Dapagliflozin versus Acarbose as a Monotherapy in Type 2 Diabetes in China. PLoS One (2016) 0.75
Effectiveness and Tolerability of Second-Line Therapy with Vildagliptin Versus Other Oral Agents in Type 2 Diabetes (EDGE): Post Hoc Sub-Analysis of Bulgarian Data. Diabetes Ther (2014) 0.75
Process quality of diabetes care under favorable access to healthcare: a 2-year longitudinal study using claims data in Japan. BMJ Open Diabetes Res Care (2016) 0.75
Machine-Learning-Based Prediction of a Missed Scheduled Clinical Appointment by Patients With Diabetes. J Diabetes Sci Technol (2016) 0.75
Relationship Between Medication Adherence and Distance to Dispensing Pharmacies and Prescribers Among an Urban Medicaid Population with Diabetes Mellitus. Pharmacotherapy (2016) 0.75
Relationship between level of HbA1C and breast cancer. BBA Clin (2016) 0.75
Pre-diagnosis blood glucose and prognosis in women with breast cancer. Cancer Metab (2016) 0.75
Previous dropout from diabetic care as a predictor of patients' willingness to use mobile applications for self-management: a cross-sectional study. J Diabetes Investig (2016) 0.75
Examining Factors Associated With Nonadherence And Identifying Providers Caring For Nonadherent Subgroups. J Pharm Health Serv Res (2017) 0.75
Assessing oral medication adherence among patients with type 2 diabetes mellitus treated with polytherapy in a developed Asian community: a cross-sectional study. BMJ Open (2017) 0.75
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care (2008) 21.05
Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med (2001) 5.68
A survey of validity and utility of electronic patient records in a general practice. BMJ (2001) 4.42
The importance of defining periods of complete mortality reporting for research using automated data from primary care. Pharmacoepidemiol Drug Saf (2009) 3.36
Correlates of insulin injection omission. Diabetes Care (2010) 3.03
Excess mortality in a population with diabetes and the impact of material deprivation: longitudinal, population based study. BMJ (2001) 2.91
Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. Am J Med (2005) 2.90
Missed appointments and poor glycemic control: an opportunity to identify high-risk diabetic patients. Med Care (2004) 2.73
Intensified glucose lowering in type 2 diabetes: time for a reappraisal. Diabetologia (2010) 2.71
Patient adherence improves glycemic control. Diabetes Educ (2005) 2.69
Prevalence, treatment, and control of diagnosed diabetes in the U.S. National Health and Nutrition Examination Survey 1999-2004. Ann Epidemiol (2008) 2.63
Information given to patients before appointments and its effect on non-attendance rate. BMJ (2001) 2.38
Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes. QJM (2007) 1.90
Clinical inertia in management of T2DM. Prim Care Diabetes (2010) 1.69
Predictors of medication nonadherence among patients with diabetes in Medicare Part D programs: a retrospective cohort study. Clin Ther (2009) 1.55
Health-related quality of life and health-adjusted life expectancy of people with diabetes in Ontario, Canada, 1996-1997. Diabetes Care (2004) 1.53
Estimation of primary care treatment costs and treatment efficacy for people with Type 1 and Type 2 diabetes in the United Kingdom from 1997 to 2007*. Diabet Med (2010) 1.06
Physician and patient management of type 2 diabetes and factors related to glycemic control in Spain. Patient Prefer Adherence (2008) 0.95
Prognostic value of physicians' assessment of compliance regarding all-cause mortality in patients with type 2 diabetes: primary care follow-up study. BMC Fam Pract (2006) 0.88
[Causes for failure of the medical appointment program in a family medicine clinic]. Rev Med Inst Mex Seguro Soc (2007) 0.85
Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet (2010) 8.27
Comparative effectiveness of weight-loss interventions in clinical practice. N Engl J Med (2011) 7.81
Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care (2005) 5.99
Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care (2008) 4.33
Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement. Diabetes Care (2010) 3.98
Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies. Diabetes Care (2012) 3.53
Meta-analysis of randomized educational and behavioral interventions in type 2 diabetes. Diabetes Educ (2003) 3.05
Correlates of insulin injection omission. Diabetes Care (2010) 3.03
National standards for diabetes self-management education. Diabetes Care (2008) 2.60
Exercise and type 2 diabetes: American College of Sports Medicine and the American Diabetes Association: joint position statement. Exercise and type 2 diabetes. Med Sci Sports Exerc (2010) 2.44
Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program. Diabetes Care (2007) 2.42
National standards for diabetes self-management education. Diabetes Care (2009) 2.36
National standards for diabetes self-management education. Diabetes Care (2012) 2.36
Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival. Diabetes Care (2012) 2.32
National standards for diabetes self-management education. Diabetes Care (2007) 2.21
Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary. Diabetes Care (2010) 2.17
One-year changes in symptoms of depression and weight in overweight/obese individuals with type 2 diabetes in the Look AHEAD study. Obesity (Silver Spring) (2011) 1.97
Behavioral and psychosocial interventions in diabetes: a conceptual review. Diabetes Care (2007) 1.96
National standards for diabetes self-management education. Diabetes Care (2010) 1.96
Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes. J Clin Endocrinol Metab (2013) 1.83
Consensus report of the coalition for clinical research-self-monitoring of blood glucose. J Diabetes Sci Technol (2008) 1.81
Diabetic peripheral neuropathy and depressive symptoms: the association revisited. Diabetes Care (2005) 1.65
National Standards for diabetes self-management education. Diabetes Care (2011) 1.60
Psychological status and weight-related distress in overweight or at-risk-for-overweight children. Obesity (Silver Spring) (2006) 1.58
Validity and reliability of an instrument for assessing health-related quality of life and treatment preferences: the Insulin Delivery System Rating Questionnaire. Diabetes Care (2005) 1.54
Diabetes self-management education core outcomes measures. Diabetes Educ (2003) 1.52
Barriers to insulin injection therapy: patient and health care provider perspectives. Diabetes Educ (2009) 1.49
Prevalence of depression in individuals with impaired glucose metabolism or undiagnosed diabetes: a systematic review and meta-analysis of the European Depression in Diabetes (EDID) Research Consortium. Diabetes Care (2011) 1.48
Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes. Curr Med Res Opin (2006) 1.44
Providers' knowledge of genetics: A survey of 5915 individuals and families with genetic conditions. Genet Med (2007) 1.42
Health care and patient-reported outcomes: results of the cross-national Diabetes Attitudes, Wishes and Needs (DAWN) study. Diabetes Care (2006) 1.34
The development and validation of a neuropathy- and foot ulcer-specific quality of life instrument. Diabetes Care (2003) 1.30
Addressing barriers to initiation of insulin in patients with type 2 diabetes. Prim Care Diabetes (2010) 1.29
Evaluation of the incremental cost to the National Health Service of prescribing analogue insulin. BMJ Open (2011) 1.29
How does treatment satisfaction work?: Modeling determinants of treatment satisfaction and preference. Diabetes Care (2009) 1.28
Associations between improved glucose control and patient-reported outcomes after initiation of insulin pump therapy in patients with type 2 diabetes mellitus. Diabetes Technol Ther (2011) 1.26
Pretreatment, psychological, and behavioral predictors of weight outcomes among lifestyle intervention participants in the Diabetes Prevention Program (DPP). Diabetes Care (2012) 1.23
STAR 3 randomized controlled trial to compare sensor-augmented insulin pump therapy with multiple daily injections in the treatment of type 1 diabetes: research design, methods, and baseline characteristics of enrolled subjects. Diabetes Technol Ther (2010) 1.23
Characterisation and comparison of health-related quality of life for patients with renal failure. Curr Med Res Opin (2005) 1.21
Effect of problem-solving-based diabetes self-management training on diabetes control in a low income patient sample. J Gen Intern Med (2011) 1.19
Impact of intensive lifestyle intervention on depression and health-related quality of life in type 2 diabetes: the Look AHEAD Trial. Diabetes Care (2014) 1.19
Factors affecting use of insulin pens by patients with type 2 diabetes. Diabetes Care (2007) 1.18
Antidepressant medicine use and risk of developing diabetes during the diabetes prevention program and diabetes prevention program outcomes study. Diabetes Care (2010) 1.15
Psychological aspects of diabetic neuropathic foot complications: an overview. Diabetes Metab Res Rev (2004) 1.14
The medico-legal aspects of prescribing vitamin D. Br J Clin Pharmacol (2014) 1.14
Patient Interpretation of Neuropathy (PIN) questionnaire: an instrument for assessment of cognitive and emotional factors associated with foot self-care. Diabetes Care (2006) 1.13
Peroxisome proliferator-activated receptor-gamma in thyroid eye disease: contraindication for thiazolidinedione use? J Clin Endocrinol Metab (2003) 1.11
Access to diabetes self-management education: results of national surveys of patients, educators, and physicians. Diabetes Educ (2009) 1.10
Development and pilot evaluation of literacy-adapted diabetes and CVD education in urban, diabetic African Americans. J Gen Intern Med (2008) 1.08
Physician and nurse use of psychosocial strategies in diabetes care: results of the cross-national Diabetes Attitudes, Wishes and Needs (DAWN) study. Diabetes Care (2006) 1.07
The impact of the overactive bladder on health-related utility and quality of life. BJU Int (2006) 1.05
National standards for diabetes self-management education. Diabetes Educ (2007) 1.03
What next after metformin? A retrospective evaluation of the outcome of second-line, glucose-lowering therapies in people with type 2 diabetes. J Clin Endocrinol Metab (2012) 1.02
Patient-reported outcomes for an integrated real-time continuous glucose monitoring/insulin pump system. Diabetes Technol Ther (2009) 1.01
Impact of lifestyle intervention and metformin on health-related quality of life: the diabetes prevention program randomized trial. J Gen Intern Med (2012) 1.00
Pulse pressure predicts cardiovascular risk in patients with type 2 diabetes mellitus. Am J Hypertens (2005) 1.00
Vitamin D: too much of a good thing? Br J Gen Pract (2014) 0.98
Access to diabetes self-management education. Diabetes Educ (2008) 0.97
Weight-related quality of life, health utility, psychological well-being, and satisfaction with exenatide once weekly compared with sitagliptin or pioglitazone after 26 weeks of treatment. Diabetes Care (2011) 0.97
Patient-reported outcomes from a 16-week open-label, multicenter study of insulin pump therapy in patients with type 2 diabetes mellitus. Diabetes Technol Ther (2010) 0.97
Diabetes distress and its association with clinical outcomes in patients with type 2 diabetes treated with pramlintide as an adjunct to insulin therapy. Diabetes Technol Ther (2008) 0.96
Positron emission tomography imaging of the serotonin transporter in subjects with a history of alcoholism. Biol Psychiatry (2004) 0.94
Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump. J Diabetes Sci Technol (2009) 0.93
Patient-reported outcomes and diabetes technology: a systematic review of the literature. Pediatr Endocrinol Rev (2010) 0.93
Validation of a novel cognitive bias task based on difference in quantity of reinforcement for assessing environmental enrichment. Anim Cogn (2013) 0.92
Psychometric properties of an instrument for assessing treatment satisfaction associated with pramlintide use. Diabetes Educ (2009) 0.92
Pulmonary hypertension in end-stage pulmonary sarcoidosis: therapeutic effect of sildenafil? J Heart Lung Transplant (2008) 0.92
Health-related quality of life and treatment satisfaction in the Sensor-Augmented Pump Therapy for A1C Reduction 3 (STAR 3) trial. Diabetes Technol Ther (2011) 0.92
Perceived medication benefits and their association with interest in using inhaled insulin in type 2 diabetes: a model of patients' cognitive framework. Patient Prefer Adherence (2011) 0.91
Using the American Association of Diabetes Educators Outcomes System to identify patient behavior change goals and diabetes educator responses. Diabetes Educ (2007) 0.91
Assessing treatment satisfaction in patients treated with pramlintide as an adjunct to insulin therapy. Curr Med Res Opin (2007) 0.90
Changing the future of diabetes. Pediatr Diabetes (2009) 0.90
Physician perception and recommendation of insulin pens for patients with type 2 diabetes mellitus. Curr Med Res Opin (2008) 0.90
A model of long-term metabolic progression of type 2 diabetes mellitus for evaluating treatment strategies. Pharmacoeconomics (2006) 0.90
Evolution of the American Association of Diabetes Educators' diabetes education outcomes project. Diabetes Educ (2007) 0.89
External validation of the UKPDS risk engine in incident type 2 diabetes: a need for new type 2 diabetes-specific risk equations. Diabetes Care (2013) 0.89
Effect of technosphere inhaled insulin on quality of life and treatment satisfaction. Diabetes Technol Ther (2010) 0.88
US nurses' perceptions of their role in diabetes care: results of the cross-national Diabetes Attitudes Wishes and Needs (DAWN) study. Diabetes Educ (2007) 0.88
The prevalence and incidence, resource use and financial costs of treating people with attention deficit/hyperactivity disorder (ADHD) in the United Kingdom (1998 to 2010). Child Adolesc Psychiatry Ment Health (2013) 0.88
Depression as a predictor of weight regain among successful weight losers in the diabetes prevention program. Diabetes Care (2012) 0.87
Chronic rejection of a lung transplant is characterized by a profile of specific autoantibodies. Immunology (2010) 0.86